Hypothesis: Metformin is a potential reproductive toxicant

Area of Science:

• Endocrinology
• Environmental Toxicology
• Reproductive Biology

Background:

• Metformin is a widely prescribed oral medication for type 2 diabetes mellitus.
• While its glucose-lowering effects are established, its precise mechanism of action remains unclear.
• Emerging evidence suggests potential reproductive side effects associated with metformin use.

Purpose of the Study:

• To investigate the potential reproductive toxicity of metformin in humans and wildlife.
• To synthesize existing evidence on metformin's impact on reproductive health.
• To hypothesize metformin as a potential reproductive toxicant.

Main Methods:

• Review of existing human and animal studies on metformin's reproductive effects.
• Analysis of metformin's presence in environmental water samples.
• Synthesis of data on testosterone levels and reproductive outcomes in exposed populations.

Main Results:

• Metformin exposure in humans is linked to reduced testosterone levels.
• Animal studies show metformin induces reproductive abnormalities, including reduced fertility and intersex conditions.
• Metformin is detected globally in freshwater and drinking water sources.

Conclusions:

• Metformin should be considered a potential reproductive toxicant for both humans and aquatic wildlife.
• Urgent research is needed to explore the association between metformin exposure and reproductive outcomes.
• Environmental contamination by metformin warrants attention regarding its ecological impact.